Ruediger E. Port

4.2k total citations · 1 hit paper
19 papers, 3.4k citations indexed

About

Ruediger E. Port is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Ruediger E. Port has authored 19 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Materials Chemistry and 2 papers in Molecular Biology. Recurrent topics in Ruediger E. Port's work include MRI in cancer diagnosis (13 papers), Advanced MRI Techniques and Applications (10 papers) and Lanthanide and Transition Metal Complexes (6 papers). Ruediger E. Port is often cited by papers focused on MRI in cancer diagnosis (13 papers), Advanced MRI Techniques and Applications (10 papers) and Lanthanide and Transition Metal Complexes (6 papers). Ruediger E. Port collaborates with scholars based in Germany, United States and France. Ruediger E. Port's co-authors include Gunnar Brix, Michael V. Knopp, Nina A. Mayr, Paul S. Tofts, June S. Taylor, Jeffrey L. Evelhoch, Geoff J.M. Parker, Elizabeth Henderson, Henrik Larsson and Robert M. Weisskoff and has published in prestigious journals such as Magnetic Resonance in Medicine, British Journal of Pharmacology and Carcinogenesis.

In The Last Decade

Ruediger E. Port

19 papers receiving 3.3k citations

Hit Papers

Estimating kinetic parameters from dynamic contrast-enhan... 1999 2026 2008 2017 1999 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruediger E. Port Germany 14 2.8k 506 282 277 239 19 3.4k
N. Jane Taylor United Kingdom 26 2.0k 0.7× 372 0.7× 85 0.3× 160 0.6× 384 1.6× 48 2.7k
H Schlemmer Germany 24 1.0k 0.4× 711 1.4× 227 0.8× 76 0.3× 147 0.6× 60 1.8k
James Stirling United Kingdom 23 1.7k 0.6× 330 0.7× 49 0.2× 116 0.4× 346 1.4× 46 2.3k
Lindsay W. Turnbull United Kingdom 37 3.5k 1.3× 1.2k 2.3× 69 0.2× 100 0.4× 121 0.5× 92 4.7k
J Vignaud France 14 2.4k 0.9× 621 1.2× 70 0.2× 39 0.1× 171 0.7× 55 3.4k
Edmond A. Knopp United States 28 2.9k 1.1× 690 1.4× 2.5k 8.7× 195 0.7× 398 1.7× 53 4.7k
Masayuki Matsuo Japan 26 1.2k 0.4× 595 1.2× 195 0.7× 87 0.3× 193 0.8× 288 2.7k
Christian Plathow Germany 31 1.6k 0.6× 1.2k 2.3× 126 0.4× 64 0.2× 260 1.1× 63 2.8k
Eric A. Mellon United States 24 1.0k 0.4× 1.1k 2.1× 272 1.0× 97 0.4× 144 0.6× 111 2.9k
Savannah C. Partridge United States 44 4.9k 1.8× 579 1.1× 94 0.3× 81 0.3× 189 0.8× 120 5.8k

Countries citing papers authored by Ruediger E. Port

Since Specialization
Citations

This map shows the geographic impact of Ruediger E. Port's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger E. Port with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger E. Port more than expected).

Fields of papers citing papers by Ruediger E. Port

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruediger E. Port. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger E. Port. The network helps show where Ruediger E. Port may publish in the future.

Co-authorship network of co-authors of Ruediger E. Port

This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger E. Port. A scholar is included among the top collaborators of Ruediger E. Port based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger E. Port. Ruediger E. Port is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ferl, Gregory Z., James P.B. O’Connor, Geoff J.M. Parker, et al.. (2014). Mixed‐effects modeling of clinical DCE‐MRI data: Application to colorectal liver metastases treated with bevacizumab. Journal of Magnetic Resonance Imaging. 41(1). 132–141. 9 indexed citations
3.
Bengtsson, Thomas, Rodney J. Hicks, Amy Peterson, & Ruediger E. Port. (2012). 18F-FDG PET as a Surrogate Biomarker in Non–Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value. Journal of Nuclear Medicine. 53(4). 530–537. 27 indexed citations
4.
Williams, Simon‐Peter, et al.. (2012). The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant. EJNMMI Research. 2(1). 35–35. 6 indexed citations
5.
Bumbaca, Daniela, Hong Xiang, C. Andrew Boswell, et al.. (2011). Maximizing tumour exposure to anti‐neuropilin‐1 antibody requires saturation of non‐tumour tissue antigenic sinks in mice. British Journal of Pharmacology. 166(1). 368–377. 33 indexed citations
6.
Port, Ruediger E., et al.. (2010). Noncompartmental kinetic analysis of DCE‐MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab. Magnetic Resonance in Medicine. 64(2). 408–417. 25 indexed citations
7.
Ferl, Gregory Z., et al.. (2010). An automated method for nonparametric kinetic analysis of clinical DCE‐MRI data: Application to glioblastoma treated with bevacizumab. Magnetic Resonance in Medicine. 63(5). 1366–1375. 34 indexed citations
9.
Leary, Robert, et al.. (2006). Parametric and Nonparametric Population Methods. Clinical Pharmacokinetics. 45(4). 365–383. 67 indexed citations
10.
Port, Ruediger E., Daniela Kiepe, Michael Van Guilder, Roger W. Jelliffe, & Otto Mehls. (2004). Recombinant Human Erythropoietin for the Treatment of Renal Anaemia in Children. Clinical Pharmacokinetics. 43(1). 57–70. 12 indexed citations
11.
Port, Ruediger E. & Walter Wolf. (2003). Noninvasive Methods to Study Drug Distribution. Investigational New Drugs. 21(2). 157–168. 13 indexed citations
12.
Port, Ruediger E., Michael V. Knopp, & Gunnar Brix. (2001). Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magnetic Resonance in Medicine. 45(6). 1030–1038. 132 indexed citations
13.
Taylor, June S., Paul S. Tofts, Ruediger E. Port, et al.. (1999). MR imaging of tumor microcirculation: Promise for the new millenium. Journal of Magnetic Resonance Imaging. 10(6). 903–907. 175 indexed citations
14.
Port, Ruediger E., et al.. (1999). Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [ 19 F]-nuclear magnetic resonance spectroscopy in vivo. Cancer Chemotherapy and Pharmacology. 44(1). 65–73. 7 indexed citations
15.
Tofts, Paul S., Gunnar Brix, David L. Buckley, et al.. (1999). Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. Journal of Magnetic Resonance Imaging. 10(3). 223–232. 2550 indexed citations breakdown →
16.
Port, Ruediger E., Michael V. Knopp, Ulf Hoffmann, Stefanie Milker-Zabel, & Gunnar Brix. (1999). Multicompartment analysis of gadolinium chelate kinetics: Blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. Journal of Magnetic Resonance Imaging. 10(3). 233–241. 130 indexed citations
17.
Port, Ruediger E., et al.. (1999). Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging. Journal of Magnetic Resonance Imaging. 10(3). 233–241. 15 indexed citations
18.
Port, Ruediger E., et al.. (1994). Anticarcinogenic Effect of Tetrachlorodecaoxide after Total-Body Gamma Irradiation in Rats. Radiation Research. 139(2). 226–226. 5 indexed citations
19.
Moolgavkar, Suresh H., et al.. (1990). Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments—I. Single agent regimen. Carcinogenesis. 11(8). 1271–1278. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026